Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients? / 대한소화기학회지
The Korean Journal of Gastroenterology
; : 329-332, 2014.
Article
in Ko
| WPRIM
| ID: wpr-62975
Responsible library:
WPRO
ABSTRACT
No abstract available.
Full text:
1
Index:
WPRIM
Main subject:
Antiviral Agents
/
Carcinoma, Hepatocellular
/
Hepatitis B, Chronic
/
Hepatitis B Surface Antigens
/
Liver Neoplasms
Limits:
Female
/
Humans
/
Male
Language:
Ko
Journal:
The Korean Journal of Gastroenterology
Year:
2014
Type:
Article